Why do we lack an effective vaccine against herpes simplex virus infections? (Q34016450)

30 July 2017

1 reference

title

Why do we lack an effective vaccine against herpes simplex virus infections? (English)

1 reference

30 July 2017

S P Deshpande

1

1 reference

30 July 2017

U Kumaraguru

series ordinal

2

1 reference

30 July 2017

B T Rouse

series ordinal

3

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

published in

Microbes and Infection

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

973-978

1 reference

Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Engineering Herpes Simplex

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Herpes simplex virus latency and the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Herpesviruses--Immune Escape Artists?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Herpes simplex virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Bacterial CpG DNA activates immune cells to signal infectious danger.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Infection and spread of alphaherpesviruses in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Pathways of viral gene expression during acute neuronal infection with HSV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Herpes simplex virus latency-associated transcript is a stable intron

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Cellular neuroimmunologic responses to ocular herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Production of key molecules by ocular neutrophils early after herpetic infection of the cornea

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Initial and innate responses to viral infections--pattern setting in immunity or disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

To kill or to cure: options in host defense against viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Secretory IgA Antibody in Cervicovaginal Secretions from Women with Genital Infection Due to Herpes Simplex Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Evolution of recurrent herpes simplex lesions. An immunohistologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Tipping the scales of herpes simplex virus reactivation: the important responses are local

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

The essence of epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Lymphocyte responses and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Selecting and maintaining a diverse T-cell repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

DNA vaccines for the prophylaxis and modulation of HSV infections

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2800%2900339-7

7 January 2021

10.1016/S1286-4579(00)00339-7

Identifiers

DOI

1 reference

30 July 2017

1 reference